Roadmap for Best-in-Class Rare Respiratory Disease Patient Care

A global pharmaceutical company aspires to deliver an elevated, future-facing standard of care to accompany the launch of a new treatment for patients with a rare and potentially terminal lung disease.

‍

In order to ensure that patients would receive a truly patient-centric, holistic treatment experience, the client needed to understand the end-to-end patient and HCP journey, as well as future shifts relating to rare disease care solutions.

Armed with clear CX impact opportunities, we handed our client an inspiring service blueprint. Next, we led the CX team in the design of service concepts with the goal of empowering patients and HCPs along key phases of the treatment journey.